About this Webinar
During this webinar, Chris Pilis, MSc, Immunology Analyst, & Rose Joachim, PhD, Managing Immunology Analyst, will present an overview of the market landscape for microbiome-targeting therapeutics for immunological diseases, drawing on key insights from GlobalData’s recently published report, Microbiome-Targeting Therapeutics in Immunology.
The webinar will last approximately 60 minutes and will cover:
Analysis of late and early-stage microbiome-targeting pipeline agents targeting gastrointestinal, dermatological, and respiratory diseases
Assessment of microbiome-targeting therapies currently in use, namely fecal microbiota transplantation
Key regulatory information and trends for microbiome-targeting agents
Unmet needs identified by key opinion leaders regarding the development of microbiome-targeting therapeutics and an analysis of strategies to address these needs
Key R&D strategies, growth drivers, and barriers in the market for microbiome-targeting therapeutics across the US and 5EU
Speakers
Chris Pilis, MSc
Chris previously worked as a Formulation Scientist within the early drug development team at Evotec Ltd, a drug-discovery alliance and development partnership company. He has also worked as a clinical and community pharmacist. In 2020, he completed his MSc Pharmaceutics degree at University College London. His thesis work explored the development of novel formulations for delayed-release intestinal drug delivery. Chris also holds a Master’s degree in Pharmacy from the Aristotle University of Thessaloniki, Greece.
Past Webinars
View more past webinarsUpcoming Webinars
View more upcoming webinarsSearch companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Access more premium companies when you subscribe to Explorer


